Alphina Therapeutics
Westport
About Alphina Therapeutics
Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients. Its focus is on leveraging the synthetic lethal context of certain cancer patient subsets that have NAD Metabolic Deficiencies (NMD) through the development of companion diagnostics. Their goal is to develop best-in-class targeted therapies against the NAD pathway nodes in patients whose cancers exhibit hallmarks of NMD and rapidly translate these into the clinic.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $40.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2021)
- Website: alphinatx.com
- Phone: +1 (203) 435-2255
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/alphina-therapeutics-93376 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.